Imexpharm Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other companies in this sector in Vietnam: Medipharco Pharmaceutical JSC (2018 sales of 987.82 billion Dong [US$42.57 million] ), Mekophar Chemical Pharma JSC (1.16 trillion Dong [US$49.88 million] ), and OPC Pharmaceutical JSC (1.00 trillion Dong [US$43.21 million] ).

Sales Analysis. During the year ended December of 2018, sales at Imexpharm Corp were 1.18 trillion Dong (US$51.07 million). This is a very small increase of 1.7% versus 2017, when the company's sales were 1.17 trillion Dong. This was the fifth consecutive year of sales increases at Imexpharm Corp (and since 2013, sales have increased a total of 41%).